EBioMedicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2019-05-11 haiyang0518

审稿速度:1.0 | 投稿命中率:25.0
经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，

90 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2024-04-09 ms6000001986535996 来自上海

审稿速度:2.0
经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉

3 0

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2024-03-29 ms3000000561056569 来自辽宁省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：经过了圣诞节，实际上可能只用了三周返回稿件

12 0

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2023-12-11 ms1000000959787142 来自天津

各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢

19 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2022-10-20 y-y-y

审稿速度:2.0
偏重的研究方向：转化医学;临床转化
经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。

133 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2024-01-17 ms2000000395345853 来自四川省

偏重的研究方向：转化医学
经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢

20 0

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2023-08-25 dujiang 来自河南省

偏重的研究方向：转化医学
经验分享：三天拒稿

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2023-11-07 ms4000002052355520 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：微生态
经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去.

34 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2023-07-12 guolihuihelan_91618321 来自荷兰

审稿速度:12.0 | 投稿命中率:5.0
经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197628, encodeId=a631219e6286a, content=审稿速度:2.0 经验分享：这个杂志真不简单，三个审稿人都很严格，然后凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b209147650, createdName=ms6000001986535996, createdTime=Tue Apr 09 17:03:13 CST 2024, time=2024-04-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196036, encodeId=633821960367d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：经过了圣诞节，实际上可能只用了三周返回稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46d8770670, createdName=ms3000000561056569, createdTime=Fri Mar 29 12:32:02 CST 2024, time=2024-03-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154513, encodeId=fd122154513b5, content=偏重的研究方向：转化医学 经验分享：三天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Fri Aug 25 11:04:49 CST 2023, time=2023-08-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2167193, encodeId=bbf0216e1939f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生态 经验分享：经验分享：6.28投的搞，两个月就审完，中间状态变了一次，又变回under review,给1个月的时间大修，10.09号返修回去., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43049052181, createdName=ms4000002052355520, createdTime=Tue Nov 07 11:22:19 CST 2023, time=2023-11-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省)]

2023-04-19 1de85404m20(暂无匿称) 来自广东省

各位大佬，投稿会给每个作者发邮件吗

87 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务